Gastroenterology News

According to published results, preoperative depressive symptom burden treatment may improve patient-centered outcomes and health trajectories after surgery.

Vibration-controlled transient elastography and serum-based noninvasive tests show a significant discrepancy in detecting liver fibrosis, according to study findings published in Obesity.

The FDA has granted an orphan drug designation to ’1104 from Revolo Biotherapeutics, a first-in-class immune-resetting peptide designed to treat eosinophilic esophagitis, according to a press release.

Chronic hepatitis B virus infection was positively linked with severe hepatic necroinflammation in children with metabolic dysfunction-associated steatotic liver disease but did not appear to affect hepatic fibrosis, according to data.

Founded in 2017 by the National Day Calendar and the Physician Moms Group, National Women Physicians Day is a time where the medical community can honor the path that female doctors have paved through history.

A regimen of pembrolizumab plus chemotherapy given before and after surgery induced a pathologic objective response in approximately 60% of patients with advanced gastric cancers, phase 2 study results published in JAMA Oncology showed.

Treatment options for children with eosinophilic esophagitis have expanded with the FDA’s approval of dupilumab for those aged 1 to 11 years who weigh at least 15 kg, according to a press release.

Adults who consume non-sugar sweeteners have differences in gut and stool microbiome compositions compared with those who do not consume non-sugar sweeteners, according to study findings published in iScience.

In this video, members of the South Asian IBD Alliance, which received Healio’s 2023 Patient Voice Disruptive Innovator Award, share how their initial goal to dispel cultural stigma has grown into a space for community, support and advocacy.

LAS VEGAS — Supplementation with prebiotic oligofructose-enriched inulin resulted in short-term microbiome changes as early as 4 weeks among children with inflammatory bowel disease, according to a presenter at Crohn’s & Colitis Congress.